TRACON Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q1 EPS results.
Portfolio Pulse from Benzinga Newsdesk
TRACON Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q1 EPS results.
May 15, 2024 | 3:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TRACON Pharmaceuticals reported worse-than-expected Q1 EPS results, leading to a decline in its share price.
The company's worse-than-expected Q1 EPS results have directly led to a decline in its share price, indicating a negative short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100